Results 91 to 100 of about 251 (162)

[Models of public care for the population with acquired brain injury in Spain: a study of the situation by Spanish autonomous communities]. [PDF]

Rev Neurol, 2022
Fernández-Sánchez M, Aza-Hernández A, Verdugo-Alonso MA.   +2 more
europepmc   +1 more source

Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]

Biomedica
Panesso GA, Martínez JD, Velasco A, Forero S, Perdomo D, Villamil Á, González ER, Jiménez CA.   +7 more
europepmc   +1 more source

[Gross Motor Function after Rehabilitation with the Atlas 2030 Pediatric Exoskeleton in Children With Cerebral Palsy]. [PDF]

Rev Neurol
García Oliveros I, Meabe Iturbe N, Marín Ojea JI, Lancho Poblador C, Fuentes-Claramonte P, Quemada Ubis JI.   +5 more
europepmc   +1 more source

[Validity and reliability of the Tardieu scale for assessing upper limb spasticity in adults with cerebrovascular disease. Systematic review]. [PDF]

Rev Neurol
Roldán-González E, Gómez-Rodríguez FJ, Jácome-Velasco SJ, Riascos-Forero Y, Rosas-Roldán LA, Hurtado-Otero ML, Sarria-Gómez AV.   +6 more
europepmc   +1 more source

Terapia com morfina intratecal para espasticidade

Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery, 2018
Fábio Okuda, Bernardo Mônaco, Manoel Teixeira   +2 more
openaire   +1 more source

Tratamiento fisioterapéutico conservador de la espasticidad

, 2017
"INTRODUCCIÓN. LA ESPASTICIDAD ES UN TRANSTORNO MOTOR COMÚN EN LAS PATOLOGÍAS DE ORIGEN CENTRAL. LOS SÍNTOMAS MÁS FRECUENTES SON: HIPERTONÍA, ESPASMOS, CLONUS, HIPERREFLEXIA, REFLEJO DE BABINSKI Y COACTIVACIÓN MUSCULAR. ES UN SIGNO DEL SÍNDROME DE LA MOTONEURONA SUPERIOR. AFECTA A LA VÍA PIRAMIDAL. LA ESPASTICIDAD TIENDE A CRONIFICARSE, DISTINGUIÉNDOSE
openaire   +1 more source

Clinical and mutational spectrum of Colombian patients with Pelizaeus Merzbacher Disease. [PDF]

Colomb Med (Cali), 2018
Velasco Parra HM, Maradei Anaya SJ, Acosta Guio JC, Arteaga Diaz CE, Prieto Rivera JC.   +4 more
europepmc   +1 more source

Toxina botulínica tipo A en espasticidad. Revisión Sistemática.

, 2016
[EN] The present work has the purpose of gather the main scientific evidences which determine the effectiveness of Botulinum Toxin Type A in patients with focal spasticity. The author realized a systematic research of randomized clinical trials in the databases PEDro, Pubmed, WOS and Scopus using the keywords “Botulinum Toxin Type A”, “Physiotherapy ...
openaire   +1 more source

[Natural history of mucopolysaccharidosis type III in a series of Colombian patients]. [PDF]

Rev Neurol
Cabarcas L, Ramón JL, Espinosa E, Guerrero GP, Martínez N, Santamaría N, Lince I, Reyes S.   +7 more
europepmc   +1 more source

Dispositivo mecatrónico para a quantificação da Espasticidade

, 2011
A Espasticidade é um distúrbio motor incapacitante, resultante de doenças neurológicas, conduzindo a perdas funcionais, distúrbios posturais e dor. Este distúrbio representa actualmente um grande impacto social e económico, estima-se que afecta aproximadamente 1.9% da população mundial. Regista-se um interesse clínico crescente no desenvolvimento de um
openaire   +1 more source